
Akums Drugs & Pharmaceuticals Ltd. (AKUMS): Akums Drugs & Pharmaceuticals Share Price hits fresh 52-week high on 31 August 2026
Updated: 31 Aug 2026 • 12:25 pm
Posted by:

Akums Drugs & Pharmaceuticals Share Price moved to Rs 781.7 on 31 August 2026, up Rs 9.2 or 1.19% from the previous close of Rs 772.5. The stock also touched a fresh 52-week high of Rs 783.9 during the session, with market capitalisation at Rs 12,158.69 crore. The event is relevant because the day’s figures confirm a new one-year high in Akums Drugs & Pharmaceuticals Share Price, while the supplied data does not establish a company-specific catalyst for the move. Univest tracks such stock news as a price event first, then places the valuation and sector context around it for readers following Akums Drugs & Pharmaceuticals Share Price today.
The session opened at Rs 779.95 and traded between Rs 769.9 and Rs 783.9. Turnover stood at Rs 0.77 crore. The stock therefore spent the day close to the upper end of its range and ended above the previous close, which is what makes this Akums Drugs & Pharmaceuticals Share Price update notable in the market news flow. For readers scanning Akums Drugs & Pharmaceuticals Stock News and Akums Drugs & Pharmaceuticals Share Price news today, the key point is straightforward: the price printed a fresh 52-week peak and held near that level into the close.
Akums Drugs & Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 781.7 |
| Previous Close | Rs 772.5 |
| Today's Move | +Rs 9.2 (+1.19%) |
| Open | Rs 779.95 |
| High | Rs 783.9 |
| Low | Rs 769.9 |
| Turnover | Rs 0.77 crore |
| Market Capitalisation | Rs 12,158.69 crore |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 781.7 versus the previous close of Rs 772.5, a rise of 1.19%. The stock opened at Rs 779.95, reached a high of Rs 783.9 and touched a low of Rs 769.9.
Akums Drugs & Pharmaceuticals Share Price today was shaped by a narrow intraday range and a close above the prior session. The stock opened at Rs 779.95, dipped to Rs 769.9, and climbed to Rs 783.9, which was also the fresh 52-week high. It settled at Rs 781.7, leaving a day gain of Rs 9.2. The move amounted to 1.19% over the previous close of Rs 772.5. In percentage terms, the stock finished about 0.27% below the session high, which shows how close the close remained to the day’s peak. Turnover of Rs 0.77 crore provides the factual trading-value context for the session and is part of the Akums Drugs & Pharmaceuticals Share Price live update on Univest.
For readers asking why Akums Drugs & Pharmaceuticals Share Price is rising today, the supplied data confirms the price event but does not establish a company-specific reason. What can be verified is that the stock registered a one-year high, closed above the previous session, and ended very near the session top. That is the core of the Akums Drugs & Pharmaceuticals Share Price story for the day, and it leads directly into the longer-term context in the fundamental section below.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 12,158.69 crore |
| P/E Ratio | 41.68x |
| P/B Ratio | 3.56x |
| ROE | 8.06% |
| ROCE | 14.77% |
| EPS | Rs 18.53 |
| Book Value Per Share | Rs 216.98 |
| Dividend Yield | 0.39% |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) fundamental metrics show P/E 41.68x, P/B 3.56x, ROE 8.06%, ROCE 14.77%. These figures provide context only and are not a buy or sell signal.
Akums Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 12158.69 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.68x, P/B at 3.56x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.06% and ROCE of 14.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 18.53, book value per share of Rs 216.98, dividend yield of 0.39%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.12x, median ROE of 11.78%, median ROCE of 13.59%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 41.68x |
| Benchmark Median P/E | 31.12x |
| Benchmark Average P/E | 48.14x |
| Benchmark P/E Range | 3.7x to 672.45x |
| Company P/B Ratio | 3.56x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 8.06% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 14.77% |
| Benchmark Median ROCE | 13.59% |
| Company Market Capitalisation | Rs 12,158.69 crore |
| Benchmark Median Market Cap | Rs 630.79 crore |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 41.68x, which is above the benchmark median of 31.12x, a difference of +33.93%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of 8.06%, which is below the benchmark median of 11.78%, a difference of -31.58%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of 14.77%, which is above the benchmark median of 13.59%, a difference of +8.68%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sequent Scientific Ltd. | VIYASH | 11,756.53 | 68.69 | 4.18 | 9.06 | 13.1 |
| CORONA Remedies Ltd. | CORONA | 12,739.95 | 64.01 | 15.79 | 27.36 | 31.74 |
| Sudeep Pharma Ltd. | SUDEEPPHRM | 13,020.15 | 71.29 | 14.09 | 25.37 | 28.5 |
| Blue Jet Healthcare Ltd. | BLUEJET | 10,912.69 | 46.45 | 4.88 | 19.88 | 27.18 |
| Jubilant Pharmova Ltd. | JUBLPHARMA | 14,049.39 | 39.9 | 1.97 | 5.97 | 8.69 |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 41.68x compared with the displayed peer median of 64.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.06% compares with a peer median of 19.88% across the companies shown in the table. ROCE stood at 14.77% versus the displayed peer median of 27.18%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 12,158.69 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Akums Drugs & Pharmaceuticals Share Price
- Akums Drugs & Pharmaceuticals Share Price touched a fresh 52-week high of Rs 783.9 and closed at Rs 781.7.
- The stock rose Rs 9.2, or 1.19%, from the previous close of Rs 772.5.
- Market capitalisation stood at Rs 12,158.69 crore on the supplied data.
- P/E was 41.68, P/B was 3.56, EPS was Rs 18.53 and book value was Rs 216.98.
- ROE was 8.06%, ROCE was 14.77% and dividend yield was 0.39%.
About Akums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company within this industry classification and provides its market-cap, valuation and financial metrics. For readers following Akums Drugs & Pharmaceuticals Share Price, this classification is the verified company context used by Univest in stock news coverage and sector analysis.
The company’s recent financial record shows revenue of Rs 11,666.29 crore in Jun 2026 and net profit of Rs 1,000.1 crore in the same period. That factual profile is the background to today’s 52-week high event in Akums Drugs & Pharmaceuticals Share Price, and it is the main company context supplied for this article.
Track Akums Drugs & Pharmaceuticals Share Price on Univest
Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Akums Drugs & Pharmaceuticals Share Price live on Univest for market capitalisation, valuation ratios, shareholding pattern, 52-week levels, company news and market insights. Univest presents the stock news flow, financial ratios and comparison context in one place for Akums Drugs & Pharmaceuticals Share Price today.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Akums Drugs & Pharmaceuticals Share Price make news today?
Ans. Akums Drugs & Pharmaceuticals Share Price made news because it hit a fresh 52-week high of Rs 783.9 and closed at Rs 781.7, up 1.19% from the previous close of Rs 772.5. The supplied data confirms the price event.
What is the current Akums Drugs & Pharmaceuticals Share Price?
Ans. The current Akums Drugs & Pharmaceuticals Share Price is Rs 781.7. It was Rs 772.5 at the previous close, and the session high of Rs 783.9 also marked the stock’s fresh 52-week peak in today’s trade.
What is the 52-week high for Akums Drugs & Pharmaceuticals Share Price?
Ans. The fresh 52-week high for Akums Drugs & Pharmaceuticals Share Price is Rs 783.9. The stock traded between Rs 769.9 and Rs 783.9 during the session and ended close to the day’s top.
How much did Akums Drugs & Pharmaceuticals Share Price move today?
Ans. Akums Drugs & Pharmaceuticals Share Price rose Rs 9.2, which equals 1.19% over the previous close. The stock opened at Rs 779.95 and closed at Rs 781.7, staying near the upper end of the day’s range.
What is the market capitalisation of Akums Drugs & Pharmaceuticals Share Price?
Ans. Akums Drugs & Pharmaceuticals Share Price has a market capitalisation of Rs 12,158.69 crore. Market capitalisation shows company size in the market and is one of the main figures readers use in stock analysis.
What is the P/E ratio of Akums Drugs & Pharmaceuticals Share Price?
Ans. The P/E ratio for Akums Drugs & Pharmaceuticals Share Price is 41.68. In the same industry sample, that sits above the median P/E of 31.12 and below the average P/E of 48.14.
How does Akums Drugs & Pharmaceuticals Share Price compare with industry peers?
Ans. Akums Drugs & Pharmaceuticals Share Price trades below Sequent Scientific, CORONA Remedies and Sudeep Pharma on P/E, while its market cap is broadly near the peer range. The supplied peer set places it in the middle on valuation.
What do ROE and ROCE show for Akums Drugs & Pharmaceuticals Share Price?
Ans. ROE for Akums Drugs & Pharmaceuticals Share Price is 8.06% and ROCE is 14.77%. ROCE is above the industry median of 13.59%, while ROE is below the industry median of 11.78%.
What do EPS and book value say about Akums Drugs & Pharmaceuticals Share Price?
Ans. EPS for Akums Drugs & Pharmaceuticals Share Price is Rs 18.53 and book value is Rs 216.98 per share. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
How does Akums Drugs & Pharmaceuticals Share Price fit the healthcare sector?
Ans. Akums Drugs & Pharmaceuticals Share Price belongs to the Healthcare sector and Pharmaceuticals & Drugs industry. Its P/E is above the industry median, while its ROCE is also above the benchmark median in the supplied sector snapshot.
Recent Articles

Nifty 50 Today: Midday Breadth Weakens on 31 August 2026
31 August 2026

Shree Renuka Sugars Ltd. (RENUKA): Shree Renuka Sugars Share Price Rises 5.11% on 31 August
31 August 2026

Suven Life Sciences Ltd. (SUVEN): Suven Life Sciences Share Price rises 5.12% to Rs 383.60
31 August 2026

The Indian Hotels Company Ltd. (INDHOTEL) Share Price Rises 2.08% Today
31 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Nifty 50 Today: Midday Breadth Weakens on 31 August 2026
Shree Renuka Sugars Ltd. (RENUKA): Shree Renuka Sugars Share Price Rises 5.11% on 31 August
Suven Life Sciences Ltd. (SUVEN): Suven Life Sciences Share Price rises 5.12% to Rs 383.60
The Indian Hotels Company Ltd. (INDHOTEL) Share Price Rises 2.08% Today
RUBICON RESEARCH LIMITED (RUBICON) Share Price Rises 2.12% Today
Popular this week
FSN E-Commerce Ventures Ltd. (NYKAA) Share Price Rises 2.44% Today

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





